BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
AEterna Zentaris (AEZS) Reports Fourth Quarter And Full-Year 2014 Financial And Operating Results 3/18/2015 7:56:16 AM
AEterna Zentaris (AEZS) Announces Closing Of US$37 Million Public Offering Of Common Shares And Warrants 3/11/2015 8:46:58 AM
AEterna Zentaris (AEZS) To Announce Fourth Quarter And Full-Year 2014 Financial And Operating Results On March 17, 2015 3/10/2015 10:29:09 AM
AEterna Zentaris (AEZS) Announces Pricing Of US$37 Million Public Offering Of Common Shares And Warrants 3/6/2015 6:51:02 AM
AEterna Zentaris (AEZS) Announces Proposed Public Offering Of Common Shares And Warrants 3/6/2015 6:40:04 AM
AEterna Zentaris (AEZS) To Present At Upcoming Biotech Showcase Conference In San Francisco 1/6/2015 9:36:23 AM
AEterna Zentaris (AEZS): Final Data For Phase 1 Portion Of Ongoing Phase 1/2 Trial With Zoptarelin Doxorubicin In Prostate Cancer Published In Clinical Cancer Research 12/29/2014 7:42:34 AM
AEterna Zentaris (AEZS) Receives Notification From NASDAQ Relating To Minimum Bid Price 12/19/2014 8:47:29 AM
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China 12/1/2014 6:24:06 AM
AEterna Zentaris (AEZS) Adds Hollings Cancer Center To Multi-National Phase 3 Trial In Endometrial Cancer 11/20/2014 9:54:39 AM
12345678910...